| Quantifying benefit–risk preferences for medical interventions: an overview of a growing empirical literature A Brett Hauber, AO Fairchild, F Reed Johnson Applied health economics and health policy 11, 319-329, 2013 | 131 | 2013 |
| Patient preferences for surgical versus medical therapy for ulcerative colitis M Bewtra, V Kilambi, AO Fairchild, CA Siegel, JD Lewis, FR Johnson Inflammatory bowel diseases 20 (1), 103-114, 2014 | 68 | 2014 |
| Inflammatory bowel disease patients’ willingness to accept medication risk to avoid future disease relapse M Bewtra, AO Fairchild, E Gilroy, DA Leiman, C Kerner, RF Johnson, ... Official journal of the American College of Gastroenterology| ACG 110 (12 …, 2015 | 42 | 2015 |
| Patient preferences for device-aided treatments indicated for advanced Parkinson disease T Marshall, A Pugh, A Fairchild, S Hass Value in Health 20 (10), 1383-1393, 2017 | 31 | 2017 |
| Patient preferences for device-aided treatments indicated for advanced Parkinson disease T Marshall, A Pugh, A Fairchild, S Hass Value in Health 20 (10), 1383-1393, 2017 | 31 | 2017 |
| Patients’ willingness to accept mitral valve procedure-associated risks varies across severity of heart failure symptoms SD Reed, AO Fairchild, FR Johnson, JM Gonzalez, RJ Mentz, MW Krucoff, ... Circulation: Cardiovascular Interventions 12 (12), e008051, 2019 | 19 | 2019 |
| What is clearance worth? Patients’ stated risk tolerance for psoriasis treatments AO Fairchild, SD Reed, FR Johnson, G Anglin, AM Wolka, RA Noel Journal of Dermatological Treatment 28 (8), 709-715, 2017 | 17 | 2017 |
| Patient benefit-risk tradeoffs for radioactive iodine-refractory differentiated thyroid cancer treatments AF Mohamed, JM González, A Fairchild Journal of Thyroid Research 2015, 2015 | 15 | 2015 |
| Patient preferences for ketamine-based antidepressant treatments in treatment-resistant depression: results from a clinical trial and panel AO Fairchild, EG Katz, SD Reed, FR Johnson, A DiBernardo, D Hough, ... Neurology, Psychiatry and Brain Research 37, 67-78, 2020 | 11 | 2020 |
| Effective partnering in conducting benefit-risk patient preference studies: perspectives from a patient advocacy organization, a pharmaceutical company, and academic stated … AM Wolka, AO Fairchild, SD Reed, G Anglin, FR Johnson, M Siegel, ... Therapeutic innovation & regulatory science 52 (4), 507-513, 2018 | 10 | 2018 |
| Benefit-risk tradeoff preferences for chronic hand eczema treatments AB Hauber, AF Mohamed, JM Gonzalez, A Otteson Fairchild, SC Zelt, ... Journal of Dermatological Treatment 28 (1), 40-46, 2017 | 10 | 2017 |
| Method for Calculating the Simultaneous Maximum Acceptable Risk Threshold (SMART) from Discrete-Choice Experiment Benefit-Risk Studies AO Fairchild, SD Reed, JM Gonzalez Medical Decision Making 43 (2), 227-238, 2023 | 4 | 2023 |
| Women's preferences for IBD medical therapy during pregnancy A Fairchild, T Kushner, FR Johnson, BE Sands, U Mahadevan, ... Gastroenterology 152 (5), S84-S85, 2017 | 4 | 2017 |
| How Does the Public Evaluate Vaccines for Low-Incidence, Severe-Outcome Diseases? A General-Population Choice Experiment FR Johnson, A Fairchild, D Whittington, AK Srivastava, JM Gonzalez, ... The Patient-Patient-Centered Outcomes Research 16 (2), 139-151, 2023 | 3 | 2023 |
| Women’s willingness to accept risks of medication for inflammatory bowel disease during pregnancy T Kushner, A Fairchild, FR Johnson, BE Sands, U Mahadevan, ... The Patient-Patient-Centered Outcomes Research, 1-13, 2021 | 3 | 2021 |
| Primary immune deficiency: patients’ preferences for replacement immunoglobulin therapy JM Gonzalez, M Ballow, A Fairchild, MC Runken Frontiers in Immunology 13, 827305, 2022 | 2 | 2022 |
| Gender Inequality, Social Movement, and Company Actions: How Do Wall Street and Main Street React? A Fairchild, O Hawn, RV Aguilera, A Colicev, Y Bart Social Movement, and Company Actions: How Do Wall Street and Main Street React, 2023 | 1 | 2023 |
| Use of Patient Preferences Data Regarding Multiple Risks to Inform Regulatory Decisions JF Montano-Campos, JM Gonzalez, T Rickert, AO Fairchild, B Levitan, ... MDM Policy & Practice 8 (1), 23814683221148715, 2023 | 1 | 2023 |
| 2. Understanding Patient Preferences for Meningococcal Serogroup B Vaccines in the United States R Johnson, A Fairchild, D Whittington, J Presa, A Srivastava, L Huang Open Forum Infectious Diseases 7 (Supplement_1), S23-S23, 2020 | 1 | 2020 |
| 281. Understanding Patient Preferences for Meningococcal Serogroup B Vaccines R Johnson, A Fairchild, L Huang, A Srivastava Journal of Adolescent Health 66 (2), S141-S142, 2020 | 1 | 2020 |
